SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

BSE Healthcare Companies

BSE Sensex 78285.07
521.16 (0.67%)

The BSE Healthcare Index is designed to reflect the behaviour and performance of mid market capitalization companies. S&P BSE Mid Cap includes all companies forming part of mid cap universe on BSE. Look for Green and Orange companies for investing. Bookmark this page for your easy reference in future.

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen :- Q: Quality, V: Valuation, PT: Price Trend

Filter

BSE Healthcare companies as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	CMP	Price Change (%)	Market Cap (Cr)	52Week High	52Week Low	ROE(%)	P/E	P/BV	EV/ EBITDA	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Fermenta Biotech Ltd	Q V PT	395	14.21%	1,163 Small Cap	401 06 Jul, 26	256 05 Dec, 25	19.19	18.08	2.75	10.93	7.46	0.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Tarsons Products Ltd	Q V+ PT	293	10.42%	1,559 Small Cap	405 22 Jul, 25	164 30 Mar, 26	5.71	68.83	2.31	13.12	12.30	-1.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Sun Pharma Advanced Research Company Ltd	Q V+ PT	262	9.41%	8,491 Small Cap	263 06 Jul, 26	108 23 Mar, 26	719.99	5.47	6.37	5.62	-1.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Artemis Medicare Services Ltd	Q V+ PT	276	6.11%	4,374 Small Cap	298 18 Nov, 25	203 13 Apr, 26	12.84	42.28	5.03	20.43	10.15	32.48	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Rubicon Research Ltd	Q V+ PT	1,363	4.61%	22,539 Small Cap	1,468 24 Jun, 26	571 24 Oct, 25	28.27	119.78	16.66	70.14	32.49	25.95	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Abbott India Ltd	Q V PT	26,852	3.87%	57,058 Mid Cap	35,280 30 Jul, 25	25,164 27 Apr, 26	35.71	36.76	11.95	25.14	9.38	18.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Caplin Point Laboratories Ltd	Q V PT	2,625	3.54%	19,954 Small Cap	2,680 01 Jul, 26	1,502 30 Mar, 26	20.20	31.12	5.56	22.06	17.55	21.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Metropolis Healthcare Ltd	Q V PT	573	3.14%	11,883 Small Cap	600 14 May, 26	413 02 Apr, 26	11.92	62.54	7.85	27.76	9.22	2.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Morepen Laboratories Ltd	Q V PT	60.78	3.03%	3,330 Small Cap	66.36 07 Jul, 25	33.44 30 Mar, 26	9.12	50.42	2.68	26.03	14.44	19.03	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Health X Platform Ltd	Q V PT	320	2.89%	1,018 Small Cap	375 13 Jan, 26	253 30 Mar, 26	-0.26	0.00	3.76	-1273.91	109.54	-201.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	3B Blackbio Dx Ltd	Q V PT	1,205	2.79%	1,034 Small Cap	1,750 19 Jan, 26	1,084 02 Jun, 26	18.95	20.97	3.79	14.19	46.29	132.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Glenmark Pharmaceuticals Ltd	Q V+ PT	2,270	2.74%	64,072 Mid Cap	2,471 29 Apr, 26	1,794 09 Jul, 25	15.43	47.05	6.10	12.50	4.60	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Granules India Ltd	Q V+ PT	854	2.55%	21,172 Small Cap	865 06 Jul, 26	433 06 Aug, 25	9.18	52.84	4.81	27.95	5.58	-0.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Dr. Lal Pathlabs Ltd	Q V PT	1,687	2.46%	28,275 Small Cap	1,804 16 Jun, 26	1,272 23 Mar, 26	22.79	55.64	11.75	31.66	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Themis Medicare Ltd	Q V PT	121	2.15%	1,114 Small Cap	148 25 Sep, 25	65.00 30 Mar, 26	7.37	0.00	4.15	123.39	15.00	7.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Jubilant Pharmova Ltd	Q V+ PT	986	1.77%	15,703 Small Cap	1,250 30 Jul, 25	784 10 Mar, 26	1.19	789.08	6.79	307.47	-24.99	-38.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Blue Jet Healthcare Ltd	Q V PT	564	1.63%	9,775 Small Cap	1,028 21 Jul, 25	325 30 Mar, 26	28.99	39.44	7.19	26.54	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Alembic Pharmaceuticals Ltd	Q V+ PT	834	1.44%	16,402 Small Cap	1,065 21 Jul, 25	635 23 Mar, 26	11.08	24.31	2.89	14.97	7.69	-8.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Advanced Enzyme Technologies Ltd	Q V PT	323	1.43%	3,615 Small Cap	420 11 May, 26	252 30 Mar, 26	16.84	27.42	5.09	20.78	7.28	11.87	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Ajanta Pharma Ltd	Q V+ PT	3,371	1.37%	42,118 Mid Cap	3,506 01 Jul, 26	2,335 30 Sep, 25	25.35	39.88	9.31	26.95	13.54	10.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Divis Laboratories Ltd	Q V PT	6,851	1.33%	1,81,867 Large Cap	7,078 08 Jul, 25	5,638 29 Sep, 25	15.14	70.82	10.85	45.20	11.65	10.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Torrent Pharmaceuticals Ltd	Q V+ PT	4,823	1.21%	1,63,246 Large Cap	4,827 06 Jul, 26	3,300 08 Jul, 25	29.04	75.46	19.46	39.62	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	JB Chemicals & Pharmaceuticals Ltd	Q V+ PT	2,391	1.16%	38,385 Small Cap	2,394 06 Jul, 26	1,603 06 Oct, 25	17.99	56.94	9.51	34.49	15.51	9.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Piramal Pharma Ltd	Q V PT	178	1.14%	23,685 Small Cap	221 17 Jul, 25	133 23 Mar, 26	6.31	33.83	2.93	18.26	10.23	-6.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Eris Lifesciences Ltd	Q V PT	1,447	1.05%	20,053 Small Cap	1,888 30 Jul, 25	1,238 23 Mar, 26	12.88	32.37	5.14	19.77	21.92	3.58	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	IOL Chemicals And Pharmaceuticals Ltd	Q V+ PT	144	0.94%	4,239 Small Cap	151 02 Jul, 26	67.14 16 Mar, 26	5.78	30.79	2.36	14.37	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Cipla Ltd	Q V PT	1,471	0.88%	1,18,854 Mid Cap	1,672 23 Oct, 25	1,166 02 Apr, 26	11.57	30.64	3.46	17.41	8.01	10.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Anuh Pharma Ltd	Q V PT	80.74	0.66%	809 Small Cap	115 08 Jul, 25	66.72 30 Mar, 26	15.31	19.71	2.30	12.12	16.60	20.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Lupin Ltd	Q V PT	2,492	0.66%	1,13,963 Mid Cap	2,505 06 Jul, 26	1,839 06 Aug, 25	20.83	21.37	5.08	12.36	8.11	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Zydus Lifesciences Ltd	Q V PT	1,148	0.62%	1,14,518 Mid Cap	1,152 06 Jul, 26	836 02 Apr, 26	20.74	22.72	4.40	13.90	10.27	30.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
31	Sanofi India Ltd	Q V PT	3,447	0.61%	7,938 Small Cap	6,099 09 Jul, 25	3,058 29 May, 26	42.80	25.62	10.18	15.87	-8.74	-7.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	KMC Speciality Hospitals (India) Ltd	Q V PT	134	0.60%	2,193 Small Cap	143 01 Jul, 26	62.50 28 Jul, 25	13.91	46.92	10.42	23.75	19.21	12.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Anthem Biosciences Ltd	Q V PT	774	0.58%	43,617 Mid Cap	873 18 Sep, 25	579 02 Feb, 26	22.86	65.05	13.84	41.99	13.62	19.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Nephrocare Health Services Ltd	Q V+ PT	676	0.54%	6,781 Small Cap	768 12 Jun, 26	445 19 Dec, 25	7.15	0.00	6.98	63.30	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Fortis Healthcare Ltd	Q V+ PT	980	0.49%	73,948 Mid Cap	1,105 13 Oct, 25	757 11 Jul, 25	1.59	321.04	8.01	135.02	15.55	-22.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Alkem Laboratories Ltd	Q V+ PT	5,598	0.48%	66,927 Mid Cap	5,933 13 Jan, 26	4,717 10 Jul, 25	17.86	30.63	4.78	22.21	5.71	10.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Sun Pharmaceutical Industries Ltd	Q V+ PT	1,913	0.44%	4,59,005 Large Cap	1,925 03 Jul, 26	1,547 26 Sep, 25	16.60	39.98	5.49	22.91	9.87	23.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Poly Medicure Ltd	Q V PT	1,686	0.38%	17,094 Small Cap	2,272 07 Jul, 25	1,184 30 Mar, 26	15.04	50.88	5.60	30.56	19.91	26.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Mankind Pharma Ltd	Q V PT	2,540	0.36%	1,04,911 Mid Cap	2,727 15 Jul, 25	1,910 23 Mar, 26	14.52	51.49	6.40	32.31	14.65	12.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Jagsonpal Pharmaceuticals Ltd	Q V+ PT	237	0.36%	1,560 Small Cap	302 28 Jul, 25	155 22 Jan, 26	19.46	36.20	6.57	20.74	11.13	39.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Glaxosmithkline Pharmaceuticals Ltd	Q V PT	2,401	0.33%	40,668 Mid Cap	3,356 07 Jul, 25	2,088 12 Jun, 26	45.95	39.26	17.81	27.00	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Jupiter Life Line Hospitals Ltd	Q V PT	1,460	0.33%	9,570 Small Cap	1,618 31 Oct, 25	1,152 02 Mar, 26	12.32	50.01	5.95	28.59	21.03	54.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Concord Biotech Ltd	Q V PT	1,284	0.31%	13,433 Small Cap	1,979 24 Jul, 25	987 02 Apr, 26	21.35	51.48	6.66	31.97	18.56	18.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Dr. Agarwals Health Care Ltd	Q V PT	481	0.31%	15,252 Small Cap	568 16 Oct, 25	402 27 Mar, 26	4.70	114.51	7.53	24.89	26.38	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Pfizer Ltd	Q V PT	4,577	0.26%	20,938 Small Cap	5,890 08 Jul, 25	4,361 29 Jun, 26	16.58	28.98	4.98	16.33	1.18	5.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Rainbow Childrens Medicare Ltd	Q V PT	1,441	0.14%	14,640 Small Cap	1,644 24 Jul, 25	1,009 02 Mar, 26	17.13	58.56	8.67	26.73	15.91	24.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	RPG Life Sciences Ltd	Q V+ PT	2,420	0.12%	4,002 Small Cap	2,716 07 Jul, 25	1,731 23 Mar, 26	18.66	34.75	6.61	22.27	12.70	21.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Aarti Pharmalabs Ltd	Q V+ PT	707	0.09%	6,409 Small Cap	972 17 Jul, 25	584 30 Mar, 26	14.73	36.37	3.23	18.26	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Gland Pharma Ltd	Q V PT	2,462	0.08%	40,621 Small Cap	2,529 30 Jun, 26	1,575 16 Mar, 26	11.53	31.26	3.76	19.04	9.35	7.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Global Health Ltd	Q V PT	1,350	-0.01%	36,284 Small Cap	1,456 08 Aug, 25	955 30 Mar, 26	15.18	73.12	9.02	41.41	16.83	34.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Fermenta Biotech	395	14.21%
Tarsons Products	293.10	10.42%
Sun Pharma Adv. Res	261.65	9.41%
Artemis MedicareServ	276.30	6.11%
Rubicon Research	1,362.85	4.61%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Supriya Lifescience	865.75	-11.62%
Acutaas Chemicals	3,514.30	-4.78%
Gufic Biosciences	375.05	-4.08%
Suven Life Sciences	314.90	-3.86%
Fischer Medical	37.87	-3.66%

News about BSE Healthcare

Jul, 2026

Blue Jet Healthcare informs about resignation of statutory auditors

Blue Jet Healthcare has informed that the Board of Directors of Blue Jet Healthcare at its meeting held on May 25, 2026, has approved the audited standalone financial statements of the Company for the financial year ended March 31, 2026, together with the notes and schedules thereto and the audit report thereon, including the comparative figures for the financial year ended March 31, 2025, prepared in accordance with the applicable provisions of the Companies Act, 2013 and the applicable accounting standards. A copy of the audited standalone financial statements together with the notes and schedules thereto along with the audit report thereon is enclosed. The audited standalone financial statements of the Company for the financial year ended March 31, 2026, together with the notes and schedules thereto and the audit report thereon, are subject to adoption by the shareholders of the Company at the ensuing Annual General Meeting. The above intimation will also be available on the website of the Company, www.bluejethealthcare.com.

The above information is a part of company's filings submitted to BSE.

Jul, 2026

Concord Biotech informs about newspaper publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Concord Biotech has enclosed copies of the newspaper advertisements published for the information of the shareholders, in compliance with the applicable provisions of the SEBI Listing Regulations and the Companies Act, 2013, read with the rules made thereunder. The advertisements contain information regarding the Company's 41st Annual General Meeting, notice of candidature for the office of Director, the record date, and the availability of the e-voting facility. Financial Express (English, All Editions); and Financial Express (Gujarati, Ahmedabad Editions).

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Sun Pharma Advanced Research Company informs about confirmation certificate

Sun Pharma Advanced Research Company has informed that it enclosed the Confirmation Certificate dated July 01, 2026, received from the Company’s Registrar and Share Transfer Agent, MUFG Intime (India) for the quarter ended June 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Granules India surges on securing sole FTF ANDA status for Sodium Oxybate

It is the generic equivalent of LUMRYZ extended-release oral suspension

Jul, 2026

Fermenta Biotech informs about press release

Fermenta Biotech has informed that the Company’s Vitamin D3 (Cholecalciferol) - Plant Source has received approval from the Food Safety and Standards Authority of India (FSSAI) for use as an ingredient in Health Supplements, Nutraceuticals and Food Products. ‘Press Release’ issued by the Company in this regard is enclosed.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Glenmark Pharmaceuticals informs about press release

Glenmark Pharmaceuticals has informed about the launch of Olanzapine for Injection, 10 mg/vial, Single?Dose Vial. Glenmark’s Olanzapine for Injection is bioequivalent and therapeutically equivalent to the reference listed drug, Zyprexa® IntraMuscular Injection 10 mg/vial, of Cheplapharm Registration GmbH [NDA 021253]. The company has attached media release.

The above information is a part of company’s filings submitted to BSE.

Track Now:

5 Star Companies Large Cap Companies Mid Cap Companies Small Cap Companies Nifty Microcap Companies Top IT Companies Tax saver funds Analyze your Equity Funds Nifty Index Funds

BSE Healthcare FAQs

You can use different criterias to arrive at the list of best stocks in the BSE Healthcare company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the BSE Healthcare companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Sun Pharma Advanced Research Company Ltd. (S)	Not Good	262	8,491	5.47	6.37	5.62	720
Sanofi Consumer Healthcare India Ltd. (S)	Not Good	4,596	10,584	41.04	23.43	28.95	71.09
Wanbury Ltd. (S)	Very Good	284	993	15.01	6.87	11.15	69.35
Glaxosmithkline Pharmaceuticals Ltd. (M)	Very Good	2,401	40,668	39.26	17.81	27.00	45.95
Procter & Gamble Health Ltd. (S)	Very Good	6,321	10,493	32.10	20.00	21.75	43.64

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Acutaas Chemicals Ltd. (S)	Very Good	3,514	28,772	213
Laurus Labs Ltd. (M)	Very Good	1,529	82,615	97.06
Granules India Ltd. (S)	Very Good	854	21,172	73.38
Neuland Laboratories Ltd. (S)	Somewhat Good	18,859	24,196	57.17
Sai Life Sciences Ltd. (S)	Very Good	1,233	26,166	55.64
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Health X Platform Ltd. (S)	Not Good	320	1,018	0.00	3.76	-1273.91	110
Fischer Medical Ventures Ltd. (S)	Not Good	37.87	2,479	0.00	7.94	-481.25	96.10
3B Blackbio Dx Ltd. (S)	Somewhat Good	1,205	1,034	20.97	3.79	14.19	46.29
Max Healthcare Institute Ltd. (M)	N/A	1,133	1,10,230	76.42	10.25	46.74	46.01
Indegene Ltd. (S)	Very Good	494	11,907	29.68	3.79	16.68	34.59

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Yatharth Hospital & Trauma Care Services Ltd. (S)	Very Good	844	8,131	85.23	5.02	49.91	138
3B Blackbio Dx Ltd. (S)	Somewhat Good	1,205	1,034	20.97	3.79	14.19	132
Neuland Laboratories Ltd. (S)	Somewhat Good	18,859	24,196	66.64	12.97	39.84	64.99
Max Healthcare Institute Ltd. (M)	N/A	1,133	1,10,230	76.42	10.25	46.74	60.18
Novartis India Ltd. (S)	Somewhat Good	1,459	3,602	38.66	4.40	22.09	54.56

You have 8 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

BSE Healthcare Companies

News about BSE Healthcare

Blue Jet Healthcare informs about resignation of statutory auditors

Concord Biotech informs about newspaper publication

Sun Pharma Advanced Research Company informs about confirmation certificate

Granules India surges on securing sole FTF ANDA status for Sodium Oxybate

Fermenta Biotech informs about press release

Glenmark Pharmaceuticals informs about press release

Track Now:

Trending Blogs

BSE Healthcare FAQs

How to select the top BSE Healthcare stocks based on RoE?

What are the best-performing stocks in the BSE Healthcare index?

Which BSE Healthcare stocks have the highest revenue growth in the past five years?

Which BSE Healthcare stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.